Saturn V Capital Management LP
AUSTIN, TX · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$683.1M2026 Q3
Positions24
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.72.6%
What Changed This Quarter?
Top Holdings
AMLX
Amylyx Pharmaceuticals
19.0%
ABVX
Abivax S.A.
7.7%
IMMX
Immix Biopharma
7.1%
PHVS
Pharvaris N.V.
6.5%
PCVX
Vaxcyte
6.4%
CELC
Celcuity
6.0%
IRON
Disc Medicine
5.9%
CADL
Candel Therapeutics
5.3%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.